Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease

Depression and anxiety are common in patients with nonalcoholic fatty liver disease (NAFLD). However, their associations with histological severity of NAFLD are unknown.

[1]  M. Taouis,et al.  Hypothalamic serotonin–insulin signaling cross-talk and alterations in a type 2 diabetic model , 2012, Molecular and Cellular Endocrinology.

[2]  J. Molinuevo,et al.  Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. , 2011, Journal of hepatology.

[3]  Hiroyasu Ito,et al.  l-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin* , 2011, The Journal of Biological Chemistry.

[4]  G. Rajkowska,et al.  The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder , 2011, Neuropsychopharmacology.

[5]  M. Stepanova,et al.  Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. , 2011, Psychosomatics.

[6]  Zubin Bhagwagar,et al.  Citalopram reduces endotoxin-induced fatigue , 2011, Brain, Behavior, and Immunity.

[7]  M. Caron,et al.  Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[8]  S. Bischoff,et al.  Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[9]  D. Heistad,et al.  Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves. , 2009, American journal of physiology. Heart and circulatory physiology.

[10]  L. Lykouras,et al.  Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample , 2008, Annals of general psychiatry.

[11]  A. McCullough.  The Epidemiology and Risk Factors of NASH , 2007 .

[12]  W. Jochum,et al.  Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. , 2007, Gastroenterology.

[13]  Sylvain Houle,et al.  Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. , 2006, Archives of general psychiatry.

[14]  R. Clouse,et al.  Depression, Anxiety, and Nonalcoholic Steatohepatitis , 2006, Psychosomatic medicine.

[15]  Masahiro Ito,et al.  Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[16]  Monica Leon,et al.  A low brain serotonergic neurotransmission in children with type 1 diabetes detected through the intensity dependence of auditory-evoked potentials. , 2006, Diabetes care.

[17]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[18]  K. Freedland,et al.  Depression-Related Hyperglycemia in Type 1 Diabetes: A Mediational Approach , 2005, Psychosomatic medicine.

[19]  A. Pocai,et al.  A brain-liver circuit regulates glucose homeostasis. , 2005, Cell metabolism.

[20]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[21]  J. George,et al.  Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? , 2004, Journal of gastroenterology and hepatology.

[22]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[23]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[24]  James G Kench,et al.  Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.

[25]  R. Carney,et al.  Pathways linking depression, adiposity, and inflammatory markers in healthy young adults , 2003, Brain, Behavior, and Immunity.

[26]  K. Freedland,et al.  Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature , 2002, International journal of psychiatry in medicine.

[27]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[28]  A. McCullough,et al.  Diabetes mellitus, obesity, and hepatic steatosis. , 2002, Seminars in gastrointestinal disease.

[29]  高松 潔,et al.  婦人科入院患者におけるメンタルヘルス : HADS(Hospital Anxiety and Depression Scale)を用いた検討 , 2001 .

[30]  M. Hongo,et al.  Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. , 2000, Metabolism: clinical and experimental.

[31]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[32]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[33]  K. Freedland,et al.  Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. , 1998, Annals of internal medicine.

[34]  R. Carney,et al.  Effects of Nortriptyline on Depression and Glycemic Control in Diabetes: Results of a Double-blind, Placebo-controlled Trial , 1997, Psychosomatic medicine.

[35]  C. Tiribelli,et al.  Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study , 1994, Hepatology.

[36]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[37]  S. Fukudo,et al.  Impact of stress on alcoholic liver injury; a histopathological study. , 1989, Journal of psychosomatic research.

[38]  J. Amsterdam,et al.  Insulin resistance after oral glucose tolerance testing in patients with major depression. , 1988, The American journal of psychiatry.

[39]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[40]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[41]  J. Mendels,et al.  Insulin Tolerance Test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects , 1982, Psychological Medicine.